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Abstract  
 
Monte Carlo (MC) methods are increasingly being utilized to support several 
aspects of commissioning and clinical operation of ion beam therapy 
facilities. In this contribution two emerging areas of MC applications are 
outlined. The value of MC modeling to promote accurate treatment planning 
is addressed via examples of application of the FLUKA code to proton and 
carbon ion therapy at the Heidelberg Ion Beam Therapy Center in 
Heidelberg, Germany, and at the Proton Therapy Center of Massachusetts 
General Hospital (MGH) Boston, USA. These include generation of basic 
data for input into the treatment planning system (TPS) and validation of the 
TPS analytical pencil-beam dose computations. Moreover, we review the 
implementation of PET/CT (Positron-Emission-Tomography / Computed-
Tomography) imaging for in-vivo verification of proton therapy at MGH. 
Here, MC is used to calculate irradiation-induced positron-emitter 
production in tissue for comparison with the +-activity measurement in 
order to infer indirect information on the actual dose delivery.  
1 Introduction 
The application of light ion beams (from protons up to carbon ions) to external beam radiotherapy is 
currently rapidly increasing worldwide. The main rationale is the favorable ionization energy-loss of 
swift charged ions in matter, resulting in the characteristic dose maximum at the end of their range, 
known as Bragg-peak [1]. Proper spatial superimposition of several Bragg-peaks of different depth 
and amplitude enables optimal conformation of the delivered dose to the tumor volume, with better 
sparing of surrounding healthy tissue in comparison to conventional photon and electron radiation. 
However, this physical advantage can be exploited clinically to its maximum extent only if millimeter 
accuracy in the localization of the beam stopping point and lateral field position in human tissue is 
guaranteed. This demands precise range measurements in representative tissue-equivalent materials as 
well as accurate calculation tools for realistic description of the electromagnetic and nuclear 
interactions of the ion beam in the heterogeneous patient tissue. Besides, non-invasive imaging 
techniques for in-vivo verification of the actual beam delivery and, in particular, of the beam range in 
the patient would be highly beneficial. Nuclear interactions resulting in detectable emerging secondary 
radiation currently offer the only possibility for this purpose for a timely evaluation during or shortly 
after irradiation. An already established technique is Positron-Emission-Tomography [2], which 
exploits the coincident detection of the emerging annihilation photons following the radioactive decay 
of +-active isotopes formed along the beam path. Due to the different physical processes involved, 
the pattern of activation induced as a by-product of the therapeutic irradiation is correlated but not 
proportional to the dose delivery. Treatment verification can be achieved by comparing the measured 
activity distribution with a calculated one [2], which requires an accurate description of fragmentation 




Monte Carlo (MC) methods offer powerful computational tools for detailed and realistic description of 
radiation transport and interaction with matter. Although the intensive computational time still 
prevents the applicability to the complex task of inverse dose optimization for daily clinical use in ion 
beam therapy, MC methods are being increasingly utilized at state-of-the-art facilities to promote high 
precision ion beam therapy. This contribution addresses two emerging and inter-connected areas of 
research on Monte Carlo and Positron-Emission-Tomography (PET), both aiming to enhance the 
precision of ion beam therapy in clinical practice for improved quality of patient care. It first illustrates 
the role of Monte Carlo modeling to support accurate ion beam treatment planning, showing examples 
of applications at the Heidelberg Ion Beam Therapy Center (HIT) in Heidelberg, Germany, and at the 
Francis H. Burr Proton Therapy Center of the Massachusetts General Hospital (MGH) Boston, USA. 
These include the generation of physical basic data required as input by the treatment planning system 
(TPS), and forward re-calculation of treatment plans for verification of the TPS analytical dose 
computation in water and in the patient anatomy as given by Computed-Tomography (CT) images. 
Moreover, we discuss the dedicated MC environment which has been implemented for the first pre-
clinical and clinical quantitative study on the feasibility and value of post-radiation PET/CT imaging 
for in-vivo verification of proton therapy at MGH.   
2 Material and methods 
All the applications presented in this work are based on the usage of FLUKA [3,4], which is a general 
purpose MC transport and interaction code originally designed for high energy physics but since 1991 
extended to cover a wider range of energies and related applications including radiation therapy. In 
particular, recent efforts of the FLUKA developing team have enhanced the capabilities of the code 
towards light ion transport, including the complex handling of nucleus-nucleus interactions in the 
entire energy range of therapeutic relevance [5,6], with the low energy models of [6] only available in 
a beta version of the code provided to the users upon request. Moreover, the code is capable to handle 
arbitrarily complex geometries, comprising voxels for easy import of CT scans with an optimised 
algorithm for minimum memory requirements and fast tracking performances.  
For all the investigated applications of FLUKA to ion beam therapy, the suggested usage of default 
physics and transport settings for hadrontherapy-oriented problems was adopted (cf. definition of the 
“DEFAULTS” option in the FLUKA manual [4]). In addition, the most updated event generators were 
activated for accurate handling of nuclear interactions and evaporation, including detailed transport of 
all heavy recoils and ions. Further freely configurable transport thresholds for hadronic and 
electromagnetic radiation were chosen as described in [7] to enable time-efficient tracking 
performances with reasonable accuracy at the requested millimetre spatial scale. Adjustable input 
parameters like primary beam momentum spread and ionization potential of water were selected 
according to available experimental information or via identification of the optimal MC configuration 
settings yielding the best agreement with available experimental data (e.g., depth-dose distributions in 
water [8]).  
For simulation of scanned [9] ion beam delivery at HIT, the FLUKA source.f user-routine (offering 
the possibility to specify arbitrary primary beam properties [4]) was customised for interpretation of 
the beam control file of the irradiation, which specifies energy, focus (i.e., transversal profile), 
direction and number of ions dynamically delivered to each scan position within the treatment field. 
For passive beam irradiation at MGH, the source.f user-routine was made able to read the binary 
phase-space input file specifying position, energy and cosine directors of the primary protons [7], as 
produced by a separate Geant4 [10] MC simulation accurately modeling the entire treatment head with 
the patient- and field-specific beam modifiers [11]. Starting from the described beam source 
information, ion transport in the patient CT was implemented using the CT stoichiometric calibration 
of Refs. [12,13] for material assignment, together with the newly implemented “CORRFACT” option 
[4] for forcing the program to follow the same semi-empirical CT-range calibration curve as the TPS 
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[7]. For other studies using phantom targets or investigating interaction in additional beamline 
elements, standard combinatorial geometry definition and known elemental composition and density 
of the materials were used in the simulation of particle transport.  
For dose calculations, the built-in scoring algorithms offered by FLUKA were utilised [4,7]. For 
scoring the spatial distribution of irradiation-induced positron emitters, the proton beam fluence was 
combined with experimental cross-sections of the main reaction channels yielding +-emitters as 
described in [7]. The resulting PET activation maps were finally obtained by introducing the imaging 
system response function and scaling factors accounting for the time course of irradiation and imaging 
as well as biological washout [13,14].  
3 Results and discussion 
FLUKA-based MC calculations have provided the parameters of the synchrotron accelerator library as 
well as the basic input data for the TPS (Syngo PT Planning, Siemens AG) which will be used for 
clinical operation at the HIT facility [15]. The FLUKA-generated accelerator library comprises the 
255 proton and carbon ion pencil-beam energies made available for treatment, providing Bragg-Peaks 
with a depth separation of 1mm (1.5mm at the higher energies) in water, and the corresponding lateral 
beam dimensions at the isocentre of the treatment unit after broadening in the fixed beamline elements 
and air gap. The FLUKA-generated TPS physical basic data consist of laterally integrated depth-dose 
profiles in water calculated for each of the 255 proton and carbon ion beam energies with and without 
the ripple filter [16], which is used to broaden the Bragg-peaks for reduction of the number of 
overlapping mono-energetic beams in depth. In addition, energy- and depth-dependent fragment 
spectra have been calculated in water for initial carbon ion beam energies sampled in steps of 10 
MeV/u in the [80,440] MeV/u interval [17], to support the TPS biological calculations based on the 
Local-Effect-Model developed at GSI Darmstadt [18]. An example of a subset of basic data depth-
dose distributions is shown in figure 1 for protons and carbon ions. In general, very good agreement 
has been observed between FLUKA calculations and experimental depth-dose distributions measured 
at representative beam energies in water [8], thus supporting the reliability of the electromagnetic and 




Figure 1: Example of FLUKA-calculated depth-dose distributions in water input into the Syngo 
treatment planning system at HIT for representative 6 energies spanning the entire interval covered by 
the FLUKA-generated accelerator library of 255 energy steps for protons without ripple filter (left) 




Figure 2: Example of FLUKA re-calculations of scanned ion beam treatment plans in water for 
different U-shaped target volumes for protons (left, in beam-eye-view) and carbon ions (right, along 
the penetration depth). 
 
 
Figure 3: Comparison between the planned (“TP dose”: XiO) and FLUKA-calculated (“MC dose”) 
dose distribution for one proton field delivered to a patient with metallic implants (marked by a circle) 
in the treatment volume at MGH. The absolute dose distribution in mGy is shown in colourwash 
display (cf. [7] for the absolute scaling of both calculated distributions), whereas the grey-scale of the 
planning-CT is in arbitrary units for display purposes. Discrepancies between the two dose 
distributions are observed in the distal part of the treatment field involving interaction of the beam 
with the implants. 
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An example of application of FLUKA to forward re-calculation of scanned proton and carbon ion 
treatment plans in water is illustrated in figure 2. Corresponding point-wise dosimetric measurements 
indicated an agreement with the FLUKA-calculated distributions within the experimental uncertainties 
of few percents (data not shown here). Spread-out Bragg-Peaks delivered by the passive beam system 
at MGH could be also reproduced in fairly good agreement with ionization chamber measurements in 
water [13]. Re-calculations [7] of treatment plans on the patient CT also showed in general good 
agreement with the TPS dose distributions (XiO, Computerized Medical Systems Inc.), except in cases 
with large tissue inhomogeneities or metallic implants (figure 3) which are more sensitive to the 
approximations introduced by the TPS pencil-like beam algorithms [7,14]. These findings are in line 
with similar investigations performed with other MC codes [21]. 
 
 
Figure 4: Example of measured (“PET Meas”) and FLUKA-calculated (“MC PET”) activity 
distributions (bottom row, shown as Bq/ml in colourwash display superimposed onto the arbitrary 
rescaled imaging- and planning- CTs, respectively) for a pituitary adenoma patient receiving two 
orthogonal proton fields followed by PET/CT imaging after a standard treatment fraction at MGH. In 
the upper row the FLUKA-calculated dose distribution is additionally compared to the treatment plan 
(XiO) to assess the consistency of the two dose calculation models. Here, the meaning of the colour 
bar is the same as in figure 3. 
 
MC-calculated activity distributions are compared to measured PET images in figure 4 for a case of 
pituitary adenoma tumour scanned for 30 min starting about 18 min after complete delivery of a 
standard proton treatment with a total fraction dose of 1.8 GyE [14]. As discussed in [13,14], 
promising agreement could be obtained between calculated and measured +-activity distributions in 
phantom materials and anatomical sites of unambiguously defined composition and reduced influence 
of washout processes. Therefore, investigations on the usage of FLUKA for application to PET 
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monitoring of a wider spectrum of primary ions are ongoing [22]. Moreover, MC has been proven to 
provide a very powerful method for studying the correlation between dose deposition and positron-
emitter yield to support the development of analytical models for fast calculation of +-production. In 
the “filtering approach” of [23], FLUKA-calculated depth-distributions of dose and positron-emitters 
for mono-energetic proton beams stopped in representative homogeneous materials were used to 
determine proper reaction-dependent filter functions to be convolved with the planned dose for very 
fast prediction of +-activation. Following the promising results of this analytical framework for 
calculation of the long-lived 11C activity contribution in offline PET/CT imaging of phantom materials 
[23] and clinical cases (figure 5), additional MC-data are being currently studied for the extension of 
the method to include also the major reaction channels of short-lived emitters for application to in-
beam and in-room PET acquisition strategies in proton therapy [24]. 
 
  
Figure 5: Application of the one-dimensional filtering approach of [23] (i.e., convolution of the 
planned dose “TP dose” with a proper filter function) along the direction of beam penetration for fast 
calculation of 11C-activation (“Filter-PET”) in a clinical case of PET/CT imaging after proton 
irradiation at MGH. The results are found in fairly good agreement with the +-activity distribution 
obtained from a full-blown FLUKA-based Monte Carlo calculation (“MC PET”). 
4 Conclusion and outlook 
Despite the still too long computational times for inverse dose optimization and daily clinical use, MC 
methods are very valuable tools to support all the main aspects of ion beam delivery, treatment 
planning and dedicated quality assurance techniques, including the imaging of emerging secondary 
radiation for surrogate information on the actual dose delivery. So far, very promising results have 
been achieved with the FLUKA code, making us concluding that it represents a suitable choice for 
transport of therapeutic proton and carbon ion beams. We do foresee that the application of MC will 
spread among the ion therapy community and play an increasing role in promoting high precision ion 
beam therapy. 
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